Alpine Global Management’s Artelo Biosciences, Inc. Warrant ARTLW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,099
| Closed | -$226 | – | 540 |
|
|
2024
Q1 | $226 | Hold |
14,099
| – | – | ﹤0.01% | 199 |
|
|
2023
Q4 | $563 | Hold |
14,099
| – | – | ﹤0.01% | 188 |
|
|
2023
Q3 | $565 | Hold |
14,099
| – | – | ﹤0.01% | 157 |
|
|
2023
Q2 | $699 | Hold |
14,099
| – | – | ﹤0.01% | 201 |
|
|
2023
Q1 | $918 | Hold |
14,099
| – | – | ﹤0.01% | 116 |
|
|
2022
Q4 | $1K | Hold |
14,099
| – | – | ﹤0.01% | 472 |
|
|
2022
Q3 | $1K | Sell |
14,099
-1
| -0% | – | ﹤0.01% | 420 |
|
|
2022
Q2 | $1K | Hold |
14,100
| – | – | ﹤0.01% | 491 |
|
|
2022
Q1 | $2 | Hold |
14,100
| – | – | ﹤0.01% | 430 |
|
|
2021
Q4 | $3K | Hold |
14,100
| – | – | ﹤0.01% | 768 |
|
|
2021
Q3 | $3K | Hold |
14,100
| – | – | ﹤0.01% | 299 |
|
|
2021
Q2 | $4K | Hold |
14,100
| – | – | ﹤0.01% | 310 |
|
|
2021
Q1 | $6K | Hold |
14,100
| – | – | ﹤0.01% | 304 |
|
|
2020
Q4 | $4K | Hold |
14,100
| – | – | ﹤0.01% | 199 |
|
|
2020
Q3 | $1K | Hold |
14,100
| – | – | ﹤0.01% | 227 |
|
|
2020
Q2 | $1K | Hold |
14,100
| – | – | ﹤0.01% | 321 |
|
|
2020
Q1 | $1K | Hold |
14,100
| – | – | ﹤0.01% | 234 |
|
|
2019
Q4 | $4K | Hold |
14,100
| – | – | ﹤0.01% | 413 |
|
|
2019
Q3 | $8K | Buy |
+14,100
| New | +$10.4K | ﹤0.01% | 82 |
|
Alpine Global Management's ARTLW Position: Q2 2024 in Review
Alpine Global Management sold out of Artelo Biosciences, Inc. Warrant (ARTLW) in Q2 2024, closing a stake of 14,099 shares — an estimated $226 sold.
Alpine Global Management first reported a position in ARTLW in Q3 2019 and held it in 19 quarters. The position peaked at $8K in Q3 2019. 0 funds tracked by Wall St. Rank hold ARTLW as of Q2 2024.
- Alpine Global Management reported no remaining Artelo Biosciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
- Alpine Global Management sold 14,099 Artelo Biosciences, Inc. Warrant shares in Q2 2024, an estimated $226.
- Alpine Global Management first reported a position in Artelo Biosciences, Inc. Warrant in Q3 2019 and held it in 19 quarters.
- Alpine Global Management's Artelo Biosciences, Inc. Warrant position peaked at $8K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Artelo Biosciences, Inc. Warrant as of Q2 2024.
Based on Alpine Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.